ArticlePloS one2018

Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma.

Luca Cozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.